泰晶科技(603738.SH):實控人喻信東及其一致行動人持股比例從37.29%減至35.9375%
格隆匯11月10日丨泰晶科技(603738.SH)公佈,公司於近日收到公司控股股東、實際控制人王丹出具的《關於股份減持計劃實施情況吿知函》。喻信東、王丹、喻信輝、喻慧玲為公司控股股東、實際控制人,王丹為喻信東的配偶,喻信輝為喻信東的弟弟,喻慧玲為喻信東的妹妹,因此,上述四人屬於《上市公司收購管理辦法》規定的一致行動人。因公司實施2020年限制性股票激勵計劃預留授予導致公司總股本增加被動稀釋和主動減持,公司控股股東、實際控制人喻信東、王丹、喻信輝、喻慧玲合計持股比例從37.2934%減少至35.9375%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.